Literature DB >> 10468557

RNA aptamers as effective protein antagonists in a multicellular organism.

H Shi1, B E Hoffman, J T Lis.   

Abstract

RNA aptamers selected against proteins can be used to modulate specific protein function. Expression of such reagents in cells and whole organisms could provide a means of dissecting and controlling molecular mechanisms in vivo. We demonstrate that Drosophila B52 protein can be specifically inhibited in vitro and in vivo by a multivalent RNA aptamer. This inhibitory aptamer RNA binds B52 avidly and inhibits B52-stimulated pre-mRNA splicing. It can be expressed in cultured cells and whole animals in a stable form that accumulates up to 10% of total mRNA. It binds B52 in vivo and suppresses all phenotypes caused by B52 overexpression. The strategies presented here should prove general in design and expression of functional and therapeutic RNAs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10468557      PMCID: PMC17837          DOI: 10.1073/pnas.96.18.10033

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Perturbation of nuclear architecture by long-distance chromosome interactions.

Authors:  A F Dernburg; K W Broman; J C Fung; W F Marshall; J Philips; D A Agard; J W Sedat
Journal:  Cell       Date:  1996-05-31       Impact factor: 41.582

Review 2.  SR proteins and splicing control.

Authors:  J L Manley; R Tacke
Journal:  Genes Dev       Date:  1996-07-01       Impact factor: 11.361

3.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

4.  Sequence-specific RNA binding by an SR protein requires RS domain phosphorylation: creation of an SRp40-specific splicing enhancer.

Authors:  R Tacke; Y Chen; J L Manley
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

Review 5.  The superfamily of arginine/serine-rich splicing factors.

Authors:  X D Fu
Journal:  RNA       Date:  1995-09       Impact factor: 4.942

6.  Rapid changes in Drosophila transcription after an instantaneous heat shock.

Authors:  T O'Brien; J T Lis
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

7.  A structured retroviral RNA element that mediates nucleocytoplasmic export of intron-containing RNA.

Authors:  R K Ernst; M Bray; D Rekosh; M L Hammarskjöld
Journal:  Mol Cell Biol       Date:  1997-01       Impact factor: 4.272

8.  The concentration of B52, an essential splicing factor and regulator of splice site choice in vitro, is critical for Drosophila development.

Authors:  M E Kraus; J T Lis
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

9.  Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2.

Authors:  P Colas; B Cohen; T Jessen; I Grishina; J McCoy; R Brent
Journal:  Nature       Date:  1996-04-11       Impact factor: 49.962

10.  Targeted gene expression as a means of altering cell fates and generating dominant phenotypes.

Authors:  A H Brand; N Perrimon
Journal:  Development       Date:  1993-06       Impact factor: 6.868

View more
  42 in total

1.  RNA sequences that work as transcriptional activating regions.

Authors:  Shamol Saha; Aseem Z Ansari; Kevin A Jarrell; Mark Ptashne; Kevin A Jarell
Journal:  Nucleic Acids Res       Date:  2003-03-01       Impact factor: 16.971

2.  Specificity of short interfering RNA determined through gene expression signatures.

Authors:  Dimitri Semizarov; Leigh Frost; Aparna Sarthy; Paul Kroeger; Donald N Halbert; Stephen W Fesik
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-13       Impact factor: 11.205

3.  Nucleic acid aptamers for target validation and therapeutic applications.

Authors:  P Shannon Pendergrast; H Nicholas Marsh; Dilara Grate; Judith M Healy; Martin Stanton
Journal:  J Biomol Tech       Date:  2005-09

Review 4.  Evidence-based consensus on the diagnosis, prevention and management of hepatitis C virus disease.

Authors:  Mahrukh Akbar Shaheen; Muhammad Idrees
Journal:  World J Hepatol       Date:  2015-03-27

5.  Endogenous expression of a high-affinity pseudoknot RNA aptamer suppresses replication of HIV-1.

Authors:  Laurent Chaloin; Maik Jörg Lehmann; Georg Sczakiel; Tobias Restle
Journal:  Nucleic Acids Res       Date:  2002-09-15       Impact factor: 16.971

6.  Aptamer-targeted cell-specific RNA interference.

Authors:  Jiehua Zhou; John J Rossi
Journal:  Silence       Date:  2010-02-01

7.  Knocking down gene function with an RNA aptamer expressed as part of an intron.

Authors:  Shengchun Wang; Xiaoching Zhao; Robert Suran; Volker M Vogt; John T Lis; Hua Shi
Journal:  Nucleic Acids Res       Date:  2010-06-11       Impact factor: 16.971

Review 8.  Riboactivators: transcription activation by noncoding RNA.

Authors:  Aseem Z Ansari
Journal:  Crit Rev Biochem Mol Biol       Date:  2009 Jan-Feb       Impact factor: 8.250

9.  Composite RNA aptamers as functional mimics of proteins.

Authors:  Daiying Xu; Hua Shi
Journal:  Nucleic Acids Res       Date:  2009-04-20       Impact factor: 16.971

10.  An RNA-based transcription activator derived from an inhibitory aptamer.

Authors:  Shengchun Wang; Jason R E Shepard; Hua Shi
Journal:  Nucleic Acids Res       Date:  2010-01-12       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.